Status:
ACTIVE_NOT_RECRUITING
Studying the Effects of Brain Stimulation on Cognitive Control and Associated EEG in Human Subjects.
Lead Sponsor:
University of Cincinnati
Conditions:
Cognitive Deficit
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
This is a basic neuroscience study of modulating brain oscillations involved in cognitive control. We will record brain signals and stimulate specific regions of the brain in human participants who ar...
Detailed Description
Cognitive control is a central element of human cognition that is impaired in several psychiatric diseases. It is closely associated with brain regions that are prominently dysregulated in disease suc...
Eligibility Criteria
Inclusion
- Adult patients who are undergoing electroencephalographic (EEG) monitoring as part of a standard clinical procedure for the treatment of pharmacologically resistant epilepsy at University of Cincinnati Medical Center.
Exclusion
- Patients who have cognitive or physical impairments that would limit their ability to participate in the cognitive testing will be excluded from the study. Other exclusions include adults unable to consent, non-English speaking patients, children age 17 and younger, pregnant women (note: pregnant women are not candidates for intracranial EEG monitoring), and prisoners.
Key Trial Info
Start Date :
June 20 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2025
Estimated Enrollment :
5 Patients enrolled
Trial Details
Trial ID
NCT05251454
Start Date
June 20 2022
End Date
December 30 2025
Last Update
July 30 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Cincinnati
Cincinnati, Ohio, United States, 45219